If you are diagnosed with prostate cancer are you a candidate to delay immediate treatment with surgery or radiation? What would be your benefits and risks of delaying treatment? If you are African American are there additional factors that you need to know and take into consideration?
Dr. H. Ballentine Carter and Dr. Edward M. Schaeffer of John Hopkins Medical Institute in Baltimore, Maryland addressed these questions when they presented at PHEN's Annual Summit on September 20th, 2013. Their presentations will be webcast as the topic for PHEN's October monthly meeting.
John Hopkins has an internationally renowned prostate cancer "active surveillance" program. PHEN's webcast of current findings from this program is an important educational opportunity.
Dr. H. Ballentine Carter
H. Ballentine Carter, MD
Professor of Urology and Oncology,
Johns Hopkins Medicine
Director, Division of Adult Urology at Brady Urological Institute
Edward M. Schaeffer, MD, PhD
Associate Professor of Urology, Oncology,
Co-Director Prostate Cancer Multi-Disciplinary Clinic
Johns Hopkins Medical Institutions
Dr. Edward M. Schaeffer
Webcast viewers will be able to submit questions via email, Facebook, and Twitter during the live webcast.
Please join us on October 9th at 6 pm.